Renal Cell Cancer Update
Role of PARP Inhibition in Ovarian Cancer with Dr Thomas Herzog
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:49:58
- Mais informações
Informações:
Sinopse
Dr Thomas Herzog from the University of Cincinnati Medical Center in Cincinnati, Ohio, discusses updates and recent changes in the use of PARP inhibitors for ovarian cancer. CME information and select publications here (http://www.researchtopractice.com/OncologyTodayOvarianPARP22).
